nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—Azelaic Acid—SRD5A2—uterine cancer	0.0149	1	CrCbGaD
Vorinostat—Squamous cell carcinoma—Medroxyprogesterone Acetate—uterine cancer	0.0114	0.0436	CcSEcCtD
Vorinostat—Thromboembolism—Progesterone—uterine cancer	0.00895	0.0344	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Etoposide—uterine cancer	0.00887	0.0341	CcSEcCtD
Vorinostat—HDAC2—oviduct—uterine cancer	0.00825	0.0301	CbGeAlD
Vorinostat—Thromboembolism—Medroxyprogesterone Acetate—uterine cancer	0.00811	0.0312	CcSEcCtD
Vorinostat—HDAC6—decidua—uterine cancer	0.00646	0.0236	CbGeAlD
Vorinostat—HDAC4—uterine cervix—uterine cancer	0.00584	0.0213	CbGeAlD
Vorinostat—HDAC3—myometrium—uterine cancer	0.00573	0.0209	CbGeAlD
Vorinostat—Embolism venous—Progesterone—uterine cancer	0.00564	0.0217	CcSEcCtD
Vorinostat—HDAC8—renal system—uterine cancer	0.00562	0.0205	CbGeAlD
Vorinostat—HDAC4—decidua—uterine cancer	0.00557	0.0203	CbGeAlD
Vorinostat—HDAC1—myometrium—uterine cancer	0.00525	0.0192	CbGeAlD
Vorinostat—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.00511	0.0196	CcSEcCtD
Vorinostat—NCOR1—uterine cervix—uterine cancer	0.00509	0.0186	CbGeAlD
Vorinostat—HDAC6—female reproductive system—uterine cancer	0.00508	0.0185	CbGeAlD
Vorinostat—HDAC8—uterus—uterine cancer	0.00501	0.0183	CbGeAlD
Vorinostat—HDAC11—decidua—uterine cancer	0.00499	0.0182	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Epirubicin—uterine cancer	0.00497	0.0191	CcSEcCtD
Vorinostat—Ureteric obstruction—Epirubicin—uterine cancer	0.00497	0.0191	CcSEcCtD
Vorinostat—HDAC11—renal system—uterine cancer	0.0049	0.0179	CbGeAlD
Vorinostat—HDAC4—uterus—uterine cancer	0.00487	0.0178	CbGeAlD
Vorinostat—NCOR1—decidua—uterine cancer	0.00485	0.0177	CbGeAlD
Vorinostat—HDAC2—exocrine gland—uterine cancer	0.00476	0.0174	CbGeAlD
Vorinostat—NCOR1—renal system—uterine cancer	0.00476	0.0174	CbGeAlD
Vorinostat—HDAC6—female gonad—uterine cancer	0.00462	0.0169	CbGeAlD
Vorinostat—Gastrointestinal toxicity—Doxorubicin—uterine cancer	0.0046	0.0177	CcSEcCtD
Vorinostat—Ureteric obstruction—Doxorubicin—uterine cancer	0.0046	0.0177	CcSEcCtD
Vorinostat—HDAC11—mammalian vulva—uterine cancer	0.00459	0.0167	CbGeAlD
Vorinostat—HDAC8—female reproductive system—uterine cancer	0.0045	0.0164	CbGeAlD
Vorinostat—HDAC3—uterine cervix—uterine cancer	0.00446	0.0163	CbGeAlD
Vorinostat—Embolism—Progesterone—uterine cancer	0.00444	0.017	CcSEcCtD
Vorinostat—HDAC4—female reproductive system—uterine cancer	0.00438	0.016	CbGeAlD
Vorinostat—HDAC11—uterus—uterine cancer	0.00437	0.016	CbGeAlD
Vorinostat—Myelosuppression—Dactinomycin—uterine cancer	0.00429	0.0165	CcSEcCtD
Vorinostat—HDAC3—decidua—uterine cancer	0.00425	0.0155	CbGeAlD
Vorinostat—Deep vein thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.0163	CcSEcCtD
Vorinostat—NCOR1—uterus—uterine cancer	0.00424	0.0155	CbGeAlD
Vorinostat—HDAC2—Teniposide—Etoposide—uterine cancer	0.00414	0.731	CbGdCrCtD
Vorinostat—HDAC1—epithelium—uterine cancer	0.00412	0.015	CbGeAlD
Vorinostat—HDAC8—female gonad—uterine cancer	0.0041	0.015	CbGeAlD
Vorinostat—HDAC1—uterine cervix—uterine cancer	0.00408	0.0149	CbGeAlD
Vorinostat—HDAC8—vagina—uterine cancer	0.00407	0.0149	CbGeAlD
Vorinostat—HDAC3—endometrium—uterine cancer	0.00403	0.0147	CbGeAlD
Vorinostat—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.00402	0.0154	CcSEcCtD
Vorinostat—HDAC9—uterine cervix—uterine cancer	0.00402	0.0147	CbGeAlD
Vorinostat—HDAC4—female gonad—uterine cancer	0.00398	0.0145	CbGeAlD
Vorinostat—HDAC1—smooth muscle tissue—uterine cancer	0.00397	0.0145	CbGeAlD
Vorinostat—HDAC11—female reproductive system—uterine cancer	0.00393	0.0143	CbGeAlD
Vorinostat—HDAC3—mammalian vulva—uterine cancer	0.0039	0.0142	CbGeAlD
Vorinostat—HDAC1—decidua—uterine cancer	0.00389	0.0142	CbGeAlD
Vorinostat—HDAC9—decidua—uterine cancer	0.00383	0.014	CbGeAlD
Vorinostat—HDAC1—renal system—uterine cancer	0.00382	0.0139	CbGeAlD
Vorinostat—NCOR1—female reproductive system—uterine cancer	0.00381	0.0139	CbGeAlD
Vorinostat—HDAC3—uterus—uterine cancer	0.00372	0.0136	CbGeAlD
Vorinostat—HDAC1—endometrium—uterine cancer	0.00369	0.0135	CbGeAlD
Vorinostat—Abscess—Progesterone—uterine cancer	0.0036	0.0138	CcSEcCtD
Vorinostat—NR0B1—female reproductive system—uterine cancer	0.00358	0.0131	CbGeAlD
Vorinostat—HDAC11—female gonad—uterine cancer	0.00357	0.013	CbGeAlD
Vorinostat—HDAC1—mammalian vulva—uterine cancer	0.00357	0.013	CbGeAlD
Vorinostat—HDAC11—vagina—uterine cancer	0.00355	0.013	CbGeAlD
Vorinostat—NCOR1—female gonad—uterine cancer	0.00347	0.0127	CbGeAlD
Vorinostat—HDAC1—uterus—uterine cancer	0.0034	0.0124	CbGeAlD
Vorinostat—HDAC9—uterus—uterine cancer	0.00335	0.0122	CbGeAlD
Vorinostat—HDAC3—female reproductive system—uterine cancer	0.00334	0.0122	CbGeAlD
Vorinostat—Neoplasm malignant—Progesterone—uterine cancer	0.00333	0.0128	CcSEcCtD
Vorinostat—Abscess—Medroxyprogesterone Acetate—uterine cancer	0.00326	0.0125	CcSEcCtD
Vorinostat—NR0B1—female gonad—uterine cancer	0.00326	0.0119	CbGeAlD
Vorinostat—Myelosuppression—Etoposide—uterine cancer	0.00311	0.0119	CcSEcCtD
Vorinostat—HDAC1—female reproductive system—uterine cancer	0.00306	0.0112	CbGeAlD
Vorinostat—HDAC3—female gonad—uterine cancer	0.00304	0.0111	CbGeAlD
Vorinostat—Neoplasm malignant—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.0116	CcSEcCtD
Vorinostat—HDAC3—vagina—uterine cancer	0.00302	0.011	CbGeAlD
Vorinostat—HDAC9—female reproductive system—uterine cancer	0.00301	0.011	CbGeAlD
Vorinostat—HDAC6—lymph node—uterine cancer	0.00297	0.0108	CbGeAlD
Vorinostat—Proteinuria—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.0113	CcSEcCtD
Vorinostat—Protein urine present—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.0111	CcSEcCtD
Vorinostat—Pulmonary embolism—Progesterone—uterine cancer	0.00285	0.0109	CcSEcCtD
Vorinostat—HDAC1—female gonad—uterine cancer	0.00278	0.0102	CbGeAlD
Vorinostat—HDAC1—vagina—uterine cancer	0.00277	0.0101	CbGeAlD
Vorinostat—HDAC9—female gonad—uterine cancer	0.00274	0.01	CbGeAlD
Vorinostat—HDAC8—lymph node—uterine cancer	0.00263	0.00962	CbGeAlD
Vorinostat—Pulmonary embolism—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00991	CcSEcCtD
Vorinostat—Thromboembolism—Epirubicin—uterine cancer	0.00257	0.00986	CcSEcCtD
Vorinostat—HDAC4—lymph node—uterine cancer	0.00256	0.00935	CbGeAlD
Vorinostat—Thromboembolism—Doxorubicin—uterine cancer	0.00238	0.00912	CcSEcCtD
Vorinostat—HDAC11—lymph node—uterine cancer	0.0023	0.00839	CbGeAlD
Vorinostat—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.0086	CcSEcCtD
Vorinostat—NCOR1—lymph node—uterine cancer	0.00223	0.00814	CbGeAlD
Vorinostat—HDAC2—epithelium—uterine cancer	0.00207	0.00756	CbGeAlD
Vorinostat—HDAC2—uterine cervix—uterine cancer	0.00205	0.0075	CbGeAlD
Vorinostat—HDAC2—smooth muscle tissue—uterine cancer	0.002	0.00728	CbGeAlD
Vorinostat—HDAC2—decidua—uterine cancer	0.00196	0.00714	CbGeAlD
Vorinostat—HDAC3—lymph node—uterine cancer	0.00195	0.00713	CbGeAlD
Vorinostat—Infection—Carboplatin—uterine cancer	0.00192	0.00738	CcSEcCtD
Vorinostat—HDAC2—renal system—uterine cancer	0.00192	0.00701	CbGeAlD
Vorinostat—HDAC2—endometrium—uterine cancer	0.00186	0.00678	CbGeAlD
Vorinostat—HDAC1—lymph node—uterine cancer	0.00179	0.00653	CbGeAlD
Vorinostat—HDAC9—lymph node—uterine cancer	0.00176	0.00643	CbGeAlD
Vorinostat—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00674	CcSEcCtD
Vorinostat—Sepsis—Dactinomycin—uterine cancer	0.00175	0.00671	CcSEcCtD
Vorinostat—Myelosuppression—Epirubicin—uterine cancer	0.00174	0.00669	CcSEcCtD
Vorinostat—HDAC2—uterus—uterine cancer	0.00171	0.00625	CbGeAlD
Vorinostat—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00655	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Progesterone—uterine cancer	0.00166	0.00638	CcSEcCtD
Vorinostat—Embolism venous—Epirubicin—uterine cancer	0.00162	0.00621	CcSEcCtD
Vorinostat—Weight decreased—Progesterone—uterine cancer	0.00162	0.00621	CcSEcCtD
Vorinostat—Hyperglycaemia—Progesterone—uterine cancer	0.00161	0.00619	CcSEcCtD
Vorinostat—Myelosuppression—Doxorubicin—uterine cancer	0.00161	0.00619	CcSEcCtD
Vorinostat—HDAC2—female reproductive system—uterine cancer	0.00154	0.00562	CbGeAlD
Vorinostat—Body temperature increased—Carboplatin—uterine cancer	0.00153	0.00587	CcSEcCtD
Vorinostat—HDAC2—Levonorgestrel—Progesterone—uterine cancer	0.00153	0.269	CbGdCrCtD
Vorinostat—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00578	CcSEcCtD
Vorinostat—Embolism venous—Doxorubicin—uterine cancer	0.0015	0.00575	CcSEcCtD
Vorinostat—Lethargy—Dactinomycin—uterine cancer	0.00149	0.00572	CcSEcCtD
Vorinostat—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00562	CcSEcCtD
Vorinostat—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00561	CcSEcCtD
Vorinostat—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00546	CcSEcCtD
Vorinostat—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00543	CcSEcCtD
Vorinostat—Oedema peripheral—Progesterone—uterine cancer	0.00141	0.00541	CcSEcCtD
Vorinostat—HDAC2—female gonad—uterine cancer	0.0014	0.00511	CbGeAlD
Vorinostat—HDAC2—vagina—uterine cancer	0.00139	0.00508	CbGeAlD
Vorinostat—Serum creatinine increased—Epirubicin—uterine cancer	0.00133	0.0051	CcSEcCtD
Vorinostat—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0049	CcSEcCtD
Vorinostat—Embolism—Epirubicin—uterine cancer	0.00127	0.00488	CcSEcCtD
Vorinostat—Sepsis—Etoposide—uterine cancer	0.00126	0.00485	CcSEcCtD
Vorinostat—Alopecia—Progesterone—uterine cancer	0.00126	0.00485	CcSEcCtD
Vorinostat—Serum creatinine increased—Doxorubicin—uterine cancer	0.00123	0.00472	CcSEcCtD
Vorinostat—Pancytopenia—Dactinomycin—uterine cancer	0.0012	0.0046	CcSEcCtD
Vorinostat—Muscle spasms—Progesterone—uterine cancer	0.0012	0.0046	CcSEcCtD
Vorinostat—Neutropenia—Dactinomycin—uterine cancer	0.00118	0.00453	CcSEcCtD
Vorinostat—Embolism—Doxorubicin—uterine cancer	0.00118	0.00452	CcSEcCtD
Vorinostat—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00446	CcSEcCtD
Vorinostat—Anaemia—Progesterone—uterine cancer	0.00115	0.00442	CcSEcCtD
Vorinostat—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0044	CcSEcCtD
Vorinostat—Angioedema—Progesterone—uterine cancer	0.00114	0.00437	CcSEcCtD
Vorinostat—Syncope—Progesterone—uterine cancer	0.00112	0.00429	CcSEcCtD
Vorinostat—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00424	CcSEcCtD
Vorinostat—Loss of consciousness—Progesterone—uterine cancer	0.00109	0.0042	CcSEcCtD
Vorinostat—Cough—Progesterone—uterine cancer	0.00109	0.00417	CcSEcCtD
Vorinostat—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00416	CcSEcCtD
Vorinostat—Chest pain—Progesterone—uterine cancer	0.00106	0.00407	CcSEcCtD
Vorinostat—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.004	CcSEcCtD
Vorinostat—Dry mouth—Progesterone—uterine cancer	0.00104	0.00398	CcSEcCtD
Vorinostat—Abscess—Epirubicin—uterine cancer	0.00103	0.00396	CcSEcCtD
Vorinostat—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00396	CcSEcCtD
Vorinostat—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00388	CcSEcCtD
Vorinostat—Infection—Progesterone—uterine cancer	0.00101	0.00388	CcSEcCtD
Vorinostat—Shock—Progesterone—uterine cancer	0.000999	0.00384	CcSEcCtD
Vorinostat—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000991	0.00381	CcSEcCtD
Vorinostat—Anorexia—Progesterone—uterine cancer	0.000968	0.00372	CcSEcCtD
Vorinostat—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00096	0.00369	CcSEcCtD
Vorinostat—Neoplasm malignant—Epirubicin—uterine cancer	0.000956	0.00367	CcSEcCtD
Vorinostat—Abscess—Doxorubicin—uterine cancer	0.000955	0.00367	CcSEcCtD
Vorinostat—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000939	0.00361	CcSEcCtD
Vorinostat—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000914	0.00351	CcSEcCtD
Vorinostat—Chills—Dactinomycin—uterine cancer	0.000907	0.00348	CcSEcCtD
Vorinostat—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000906	0.00348	CcSEcCtD
Vorinostat—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.00346	CcSEcCtD
Vorinostat—HDAC2—lymph node—uterine cancer	0.0009	0.00329	CbGeAlD
Vorinostat—Alopecia—Dactinomycin—uterine cancer	0.000893	0.00343	CcSEcCtD
Vorinostat—Neoplasm malignant—Doxorubicin—uterine cancer	0.000885	0.0034	CcSEcCtD
Vorinostat—Decreased appetite—Progesterone—uterine cancer	0.000883	0.00339	CcSEcCtD
Vorinostat—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.00337	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Progesterone—uterine cancer	0.000877	0.00337	CcSEcCtD
Vorinostat—Fatigue—Progesterone—uterine cancer	0.000876	0.00336	CcSEcCtD
Vorinostat—Constipation—Progesterone—uterine cancer	0.000869	0.00334	CcSEcCtD
Vorinostat—Pancytopenia—Etoposide—uterine cancer	0.000868	0.00333	CcSEcCtD
Vorinostat—Neutropenia—Etoposide—uterine cancer	0.000854	0.00328	CcSEcCtD
Vorinostat—Pulmonary embolism—Epirubicin—uterine cancer	0.000816	0.00314	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—uterine cancer	0.000813	0.00312	CcSEcCtD
Vorinostat—Acute coronary syndrome—Etoposide—uterine cancer	0.000803	0.00308	CcSEcCtD
Vorinostat—Body temperature increased—Progesterone—uterine cancer	0.000803	0.00308	CcSEcCtD
Vorinostat—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.0008	0.00307	CcSEcCtD
Vorinostat—Myocardial infarction—Etoposide—uterine cancer	0.000799	0.00307	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.00305	CcSEcCtD
Vorinostat—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000794	0.00305	CcSEcCtD
Vorinostat—Leukopenia—Dactinomycin—uterine cancer	0.000787	0.00302	CcSEcCtD
Vorinostat—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000787	0.00302	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—uterine cancer	0.000755	0.0029	CcSEcCtD
Vorinostat—Asthenia—Progesterone—uterine cancer	0.000729	0.0028	CcSEcCtD
Vorinostat—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00279	CcSEcCtD
Vorinostat—Pruritus—Progesterone—uterine cancer	0.000719	0.00276	CcSEcCtD
Vorinostat—Infection—Dactinomycin—uterine cancer	0.000713	0.00274	CcSEcCtD
Vorinostat—Sepsis—Epirubicin—uterine cancer	0.000708	0.00272	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—uterine cancer	0.000703	0.0027	CcSEcCtD
Vorinostat—Diarrhoea—Progesterone—uterine cancer	0.000695	0.00267	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—uterine cancer	0.000684	0.00263	CcSEcCtD
Vorinostat—Dizziness—Progesterone—uterine cancer	0.000672	0.00258	CcSEcCtD
Vorinostat—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00066	0.00254	CcSEcCtD
Vorinostat—Chills—Etoposide—uterine cancer	0.000656	0.00252	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—uterine cancer	0.000656	0.00252	CcSEcCtD
Vorinostat—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000651	0.0025	CcSEcCtD
Vorinostat—Alopecia—Etoposide—uterine cancer	0.000646	0.00248	CcSEcCtD
Vorinostat—Vomiting—Progesterone—uterine cancer	0.000646	0.00248	CcSEcCtD
Vorinostat—Headache—Progesterone—uterine cancer	0.000636	0.00244	CcSEcCtD
Vorinostat—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.00242	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000628	0.00241	CcSEcCtD
Vorinostat—Decreased appetite—Dactinomycin—uterine cancer	0.000624	0.0024	CcSEcCtD
Vorinostat—Dysgeusia—Etoposide—uterine cancer	0.000623	0.00239	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—uterine cancer	0.000619	0.00238	CcSEcCtD
Vorinostat—Muscle spasms—Etoposide—uterine cancer	0.000612	0.00235	CcSEcCtD
Vorinostat—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000609	0.00234	CcSEcCtD
Vorinostat—Lethargy—Epirubicin—uterine cancer	0.000605	0.00232	CcSEcCtD
Vorinostat—Nausea—Progesterone—uterine cancer	0.000603	0.00232	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000593	0.00228	CcSEcCtD
Vorinostat—Anaemia—Etoposide—uterine cancer	0.000588	0.00226	CcSEcCtD
Vorinostat—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000585	0.00225	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000581	0.00223	CcSEcCtD
Vorinostat—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000577	0.00221	CcSEcCtD
Vorinostat—Leukopenia—Etoposide—uterine cancer	0.00057	0.00219	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—uterine cancer	0.000568	0.00218	CcSEcCtD
Vorinostat—Loss of consciousness—Etoposide—uterine cancer	0.00056	0.00215	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—uterine cancer	0.00056	0.00215	CcSEcCtD
Vorinostat—Cough—Etoposide—uterine cancer	0.000556	0.00213	CcSEcCtD
Vorinostat—Blood creatinine increased—Epirubicin—uterine cancer	0.000555	0.00213	CcSEcCtD
Vorinostat—Dehydration—Epirubicin—uterine cancer	0.000551	0.00212	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000548	0.00211	CcSEcCtD
Vorinostat—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000547	0.0021	CcSEcCtD
Vorinostat—Chest pain—Etoposide—uterine cancer	0.000542	0.00208	CcSEcCtD
Vorinostat—Hypokalaemia—Epirubicin—uterine cancer	0.000539	0.00207	CcSEcCtD
Vorinostat—Infection—Etoposide—uterine cancer	0.000516	0.00198	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—uterine cancer	0.000515	0.00198	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—uterine cancer	0.000514	0.00197	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—uterine cancer	0.00051	0.00196	CcSEcCtD
Vorinostat—Thrombocytopenia—Etoposide—uterine cancer	0.000509	0.00195	CcSEcCtD
Vorinostat—Hypokalaemia—Doxorubicin—uterine cancer	0.000499	0.00192	CcSEcCtD
Vorinostat—Anorexia—Etoposide—uterine cancer	0.000495	0.0019	CcSEcCtD
Vorinostat—Diarrhoea—Dactinomycin—uterine cancer	0.000491	0.00189	CcSEcCtD
Vorinostat—Pancytopenia—Epirubicin—uterine cancer	0.000486	0.00187	CcSEcCtD
Vorinostat—Neutropenia—Epirubicin—uterine cancer	0.000479	0.00184	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000476	0.00183	CcSEcCtD
Vorinostat—Weight decreased—Epirubicin—uterine cancer	0.000463	0.00178	CcSEcCtD
Vorinostat—Hyperglycaemia—Epirubicin—uterine cancer	0.000462	0.00177	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—uterine cancer	0.000456	0.00175	CcSEcCtD
Vorinostat—Decreased appetite—Etoposide—uterine cancer	0.000452	0.00173	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—uterine cancer	0.00045	0.00173	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Etoposide—uterine cancer	0.000449	0.00172	CcSEcCtD
Vorinostat—Fatigue—Etoposide—uterine cancer	0.000448	0.00172	CcSEcCtD
Vorinostat—Constipation—Etoposide—uterine cancer	0.000444	0.00171	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—uterine cancer	0.000443	0.0017	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00044	0.00169	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—uterine cancer	0.000429	0.00165	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—uterine cancer	0.000428	0.00164	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—uterine cancer	0.000426	0.00164	CcSEcCtD
Vorinostat—Body temperature increased—Etoposide—uterine cancer	0.000411	0.00158	CcSEcCtD
Vorinostat—Oedema peripheral—Epirubicin—uterine cancer	0.000404	0.00155	CcSEcCtD
Vorinostat—Oedema peripheral—Doxorubicin—uterine cancer	0.000374	0.00144	CcSEcCtD
Vorinostat—Asthenia—Etoposide—uterine cancer	0.000373	0.00143	CcSEcCtD
Vorinostat—Chills—Epirubicin—uterine cancer	0.000368	0.00141	CcSEcCtD
Vorinostat—Pruritus—Etoposide—uterine cancer	0.000368	0.00141	CcSEcCtD
Vorinostat—Alopecia—Epirubicin—uterine cancer	0.000362	0.00139	CcSEcCtD
Vorinostat—Diarrhoea—Etoposide—uterine cancer	0.000356	0.00137	CcSEcCtD
Vorinostat—Dysgeusia—Epirubicin—uterine cancer	0.000349	0.00134	CcSEcCtD
Vorinostat—Dizziness—Etoposide—uterine cancer	0.000344	0.00132	CcSEcCtD
Vorinostat—Muscle spasms—Epirubicin—uterine cancer	0.000343	0.00132	CcSEcCtD
Vorinostat—Chills—Doxorubicin—uterine cancer	0.00034	0.00131	CcSEcCtD
Vorinostat—Alopecia—Doxorubicin—uterine cancer	0.000335	0.00129	CcSEcCtD
Vorinostat—Vomiting—Etoposide—uterine cancer	0.00033	0.00127	CcSEcCtD
Vorinostat—Anaemia—Epirubicin—uterine cancer	0.00033	0.00127	CcSEcCtD
Vorinostat—Headache—Etoposide—uterine cancer	0.000326	0.00125	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—uterine cancer	0.000323	0.00124	CcSEcCtD
Vorinostat—Syncope—Epirubicin—uterine cancer	0.00032	0.00123	CcSEcCtD
Vorinostat—Leukopenia—Epirubicin—uterine cancer	0.000319	0.00123	CcSEcCtD
Vorinostat—Muscle spasms—Doxorubicin—uterine cancer	0.000317	0.00122	CcSEcCtD
Vorinostat—Loss of consciousness—Epirubicin—uterine cancer	0.000314	0.0012	CcSEcCtD
Vorinostat—Cough—Epirubicin—uterine cancer	0.000311	0.0012	CcSEcCtD
Vorinostat—Nausea—Etoposide—uterine cancer	0.000309	0.00119	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—uterine cancer	0.000305	0.00117	CcSEcCtD
Vorinostat—Chest pain—Epirubicin—uterine cancer	0.000304	0.00117	CcSEcCtD
Vorinostat—Dry mouth—Epirubicin—uterine cancer	0.000297	0.00114	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—uterine cancer	0.000296	0.00114	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—uterine cancer	0.000296	0.00114	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—uterine cancer	0.00029	0.00111	CcSEcCtD
Vorinostat—Infection—Epirubicin—uterine cancer	0.000289	0.00111	CcSEcCtD
Vorinostat—Cough—Doxorubicin—uterine cancer	0.000288	0.00111	CcSEcCtD
Vorinostat—Shock—Epirubicin—uterine cancer	0.000287	0.0011	CcSEcCtD
Vorinostat—Thrombocytopenia—Epirubicin—uterine cancer	0.000285	0.0011	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—uterine cancer	0.000281	0.00108	CcSEcCtD
Vorinostat—Anorexia—Epirubicin—uterine cancer	0.000278	0.00107	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—uterine cancer	0.000275	0.00106	CcSEcCtD
Vorinostat—Infection—Doxorubicin—uterine cancer	0.000268	0.00103	CcSEcCtD
Vorinostat—Shock—Doxorubicin—uterine cancer	0.000265	0.00102	CcSEcCtD
Vorinostat—Thrombocytopenia—Doxorubicin—uterine cancer	0.000264	0.00101	CcSEcCtD
Vorinostat—Anorexia—Doxorubicin—uterine cancer	0.000257	0.000987	CcSEcCtD
Vorinostat—Decreased appetite—Epirubicin—uterine cancer	0.000253	0.000972	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000251	0.000966	CcSEcCtD
Vorinostat—Fatigue—Epirubicin—uterine cancer	0.000251	0.000964	CcSEcCtD
Vorinostat—Constipation—Epirubicin—uterine cancer	0.000249	0.000957	CcSEcCtD
Vorinostat—Decreased appetite—Doxorubicin—uterine cancer	0.000234	0.0009	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000233	0.000894	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—uterine cancer	0.000232	0.000892	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—uterine cancer	0.00023	0.000885	CcSEcCtD
Vorinostat—Body temperature increased—Epirubicin—uterine cancer	0.00023	0.000884	CcSEcCtD
Vorinostat—Body temperature increased—Doxorubicin—uterine cancer	0.000213	0.000818	CcSEcCtD
Vorinostat—Asthenia—Epirubicin—uterine cancer	0.000209	0.000803	CcSEcCtD
Vorinostat—Pruritus—Epirubicin—uterine cancer	0.000206	0.000791	CcSEcCtD
Vorinostat—Diarrhoea—Epirubicin—uterine cancer	0.000199	0.000765	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—uterine cancer	0.000193	0.000743	CcSEcCtD
Vorinostat—Dizziness—Epirubicin—uterine cancer	0.000193	0.00074	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—uterine cancer	0.000191	0.000732	CcSEcCtD
Vorinostat—Vomiting—Epirubicin—uterine cancer	0.000185	0.000711	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—uterine cancer	0.000184	0.000708	CcSEcCtD
Vorinostat—Headache—Epirubicin—uterine cancer	0.000182	0.000701	CcSEcCtD
Vorinostat—Dizziness—Doxorubicin—uterine cancer	0.000178	0.000684	CcSEcCtD
Vorinostat—Nausea—Epirubicin—uterine cancer	0.000173	0.000664	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—uterine cancer	0.000171	0.000658	CcSEcCtD
Vorinostat—Headache—Doxorubicin—uterine cancer	0.000169	0.000648	CcSEcCtD
Vorinostat—Nausea—Doxorubicin—uterine cancer	0.00016	0.000615	CcSEcCtD
Vorinostat—HDAC4—Disease—EP300—uterine cancer	4.47e-05	0.0001	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CTNNB1—uterine cancer	4.44e-05	9.98e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CTNNB1—uterine cancer	4.44e-05	9.96e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.43e-05	9.95e-05	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—AKT1—uterine cancer	4.41e-05	9.9e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CDKN1B—uterine cancer	4.39e-05	9.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—KRAS—uterine cancer	4.39e-05	9.86e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—FGFR2—uterine cancer	4.37e-05	9.81e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—PIK3CA—uterine cancer	4.36e-05	9.8e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—PTEN—uterine cancer	4.33e-05	9.72e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PTEN—uterine cancer	4.32e-05	9.71e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—KRAS—uterine cancer	4.32e-05	9.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SOCS3—uterine cancer	4.27e-05	9.59e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—ERBB2—uterine cancer	4.26e-05	9.57e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCL2—uterine cancer	4.26e-05	9.57e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—ERBB2—uterine cancer	4.25e-05	9.56e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—NRAS—uterine cancer	4.18e-05	9.39e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CTNNB1—uterine cancer	4.15e-05	9.32e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—EP300—uterine cancer	4.13e-05	9.27e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—EP300—uterine cancer	4.12e-05	9.26e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN2B—uterine cancer	4.09e-05	9.18e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—ESR1—uterine cancer	4.06e-05	9.13e-05	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—AKT1—uterine cancer	4.05e-05	9.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—CDKN2B—uterine cancer	4.05e-05	9.1e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PTEN—uterine cancer	4.04e-05	9.08e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—HRAS—uterine cancer	4.03e-05	9.06e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CXCL8—uterine cancer	4.03e-05	9.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—PIK3CA—uterine cancer	4.03e-05	9.06e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCL2—uterine cancer	3.98e-05	8.95e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—KRAS—uterine cancer	3.98e-05	8.94e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IGF1R—uterine cancer	3.97e-05	8.91e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—PIK3CA—uterine cancer	3.97e-05	8.91e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CDKN1B—uterine cancer	3.95e-05	8.86e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CDKN1B—uterine cancer	3.94e-05	8.85e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—ERBB2—uterine cancer	3.91e-05	8.79e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—VEGFA—uterine cancer	3.91e-05	8.78e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—NRAS—uterine cancer	3.86e-05	8.68e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—NRAS—uterine cancer	3.86e-05	8.67e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—EP300—uterine cancer	3.86e-05	8.66e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—ERBB2—uterine cancer	3.85e-05	8.64e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—uterine cancer	3.84e-05	8.62e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKR1C3—uterine cancer	3.77e-05	8.47e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN2B—uterine cancer	3.76e-05	8.45e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ESR1—uterine cancer	3.73e-05	8.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—HRAS—uterine cancer	3.73e-05	8.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SMAD3—uterine cancer	3.73e-05	8.38e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CTNNB1—uterine cancer	3.73e-05	8.37e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CTNNB1—uterine cancer	3.72e-05	8.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SMAD3—uterine cancer	3.7e-05	8.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PGR—uterine cancer	3.67e-05	8.25e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—HRAS—uterine cancer	3.67e-05	8.24e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—PIK3CA—uterine cancer	3.65e-05	8.21e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CXCL8—uterine cancer	3.65e-05	8.2e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PTEN—uterine cancer	3.63e-05	8.16e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PTEN—uterine cancer	3.63e-05	8.15e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CDKN1B—uterine cancer	3.63e-05	8.14e-05	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—uterine cancer	3.62e-05	8.13e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NRAS—uterine cancer	3.61e-05	8.11e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KRAS—uterine cancer	3.6e-05	8.08e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCL2—uterine cancer	3.58e-05	8.04e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CDKN1B—uterine cancer	3.56e-05	8e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—AKT1—uterine cancer	3.56e-05	8e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FGFR2—uterine cancer	3.56e-05	7.99e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—ERBB2—uterine cancer	3.55e-05	7.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—YWHAE—uterine cancer	3.51e-05	7.87e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EP300—uterine cancer	3.46e-05	7.78e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EP300—uterine cancer	3.46e-05	7.77e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—EP300—uterine cancer	3.45e-05	7.76e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SMAD3—uterine cancer	3.43e-05	7.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CTNNB1—uterine cancer	3.42e-05	7.69e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—HRAS—uterine cancer	3.38e-05	7.6e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CXCL8—uterine cancer	3.37e-05	7.56e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CTNNB1—uterine cancer	3.37e-05	7.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FBXW7—uterine cancer	3.36e-05	7.55e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PTEN—uterine cancer	3.34e-05	7.5e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—KRAS—uterine cancer	3.32e-05	7.47e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—ERBB2—uterine cancer	3.32e-05	7.46e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KRAS—uterine cancer	3.32e-05	7.46e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—PIK3CA—uterine cancer	3.3e-05	7.42e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—AKT1—uterine cancer	3.29e-05	7.4e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCL2—uterine cancer	3.29e-05	7.39e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CDKN1B—uterine cancer	3.29e-05	7.39e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PTEN—uterine cancer	3.28e-05	7.37e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—uterine cancer	3.28e-05	7.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FGFR2—uterine cancer	3.27e-05	7.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—uterine cancer	3.27e-05	7.35e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NRAS—uterine cancer	3.24e-05	7.28e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—AKT1—uterine cancer	3.24e-05	7.28e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NRAS—uterine cancer	3.24e-05	7.27e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NRAS—uterine cancer	3.23e-05	7.26e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ERBB2—uterine cancer	3.19e-05	7.17e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EP300—uterine cancer	3.18e-05	7.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MTHFR—uterine cancer	3.15e-05	7.08e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CXCL8—uterine cancer	3.15e-05	7.07e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EP300—uterine cancer	3.13e-05	7.03e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CTNNB1—uterine cancer	3.11e-05	6.98e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KRAS—uterine cancer	3.11e-05	6.98e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CDKN1B—uterine cancer	3.08e-05	6.91e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HRAS—uterine cancer	3.06e-05	6.87e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—PIK3CA—uterine cancer	3.05e-05	6.86e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PIK3CA—uterine cancer	3.05e-05	6.85e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ESR1—uterine cancer	3.04e-05	6.84e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTEN—uterine cancer	3.04e-05	6.83e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PTEN—uterine cancer	3.03e-05	6.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—ESR1—uterine cancer	3.02e-05	6.78e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—AKT1—uterine cancer	2.99e-05	6.71e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—ERBB2—uterine cancer	2.98e-05	6.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NRAS—uterine cancer	2.98e-05	6.69e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—uterine cancer	2.96e-05	6.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1B—uterine cancer	2.96e-05	6.64e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—uterine cancer	2.95e-05	6.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STK11—uterine cancer	2.94e-05	6.6e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NRAS—uterine cancer	2.93e-05	6.58e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CTNNB1—uterine cancer	2.91e-05	6.53e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—EP300—uterine cancer	2.9e-05	6.52e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EP300—uterine cancer	2.89e-05	6.49e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PIK3CA—uterine cancer	2.85e-05	6.41e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PTEN—uterine cancer	2.83e-05	6.36e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CXCL8—uterine cancer	2.83e-05	6.35e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—HRAS—uterine cancer	2.83e-05	6.35e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HRAS—uterine cancer	2.82e-05	6.34e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTEN—uterine cancer	2.8e-05	6.28e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CTNNB1—uterine cancer	2.79e-05	6.27e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—uterine cancer	2.79e-05	6.27e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—uterine cancer	2.79e-05	6.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—uterine cancer	2.78e-05	6.25e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1B—uterine cancer	2.76e-05	6.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SOCS3—uterine cancer	2.75e-05	6.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—uterine cancer	2.74e-05	6.16e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—uterine cancer	2.73e-05	6.14e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTEN—uterine cancer	2.72e-05	6.11e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NRAS—uterine cancer	2.7e-05	6.07e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EP300—uterine cancer	2.7e-05	6.07e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—AKT1—uterine cancer	2.7e-05	6.07e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCL2—uterine cancer	2.68e-05	6.02e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—EP300—uterine cancer	2.67e-05	5.99e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HRAS—uterine cancer	2.64e-05	5.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN2B—uterine cancer	2.63e-05	5.92e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—uterine cancer	2.61e-05	5.86e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CXCL8—uterine cancer	2.6e-05	5.84e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EP300—uterine cancer	2.6e-05	5.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—uterine cancer	2.56e-05	5.76e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—uterine cancer	2.56e-05	5.76e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—uterine cancer	2.56e-05	5.75e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—uterine cancer	2.56e-05	5.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1R—uterine cancer	2.56e-05	5.74e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—uterine cancer	2.56e-05	5.74e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTEN—uterine cancer	2.54e-05	5.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1B—uterine cancer	2.54e-05	5.7e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NRAS—uterine cancer	2.53e-05	5.68e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—uterine cancer	2.52e-05	5.66e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—AKT1—uterine cancer	2.49e-05	5.6e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—AKT1—uterine cancer	2.49e-05	5.6e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—uterine cancer	2.48e-05	5.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—uterine cancer	2.47e-05	5.55e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—AKT1—uterine cancer	2.44e-05	5.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NRAS—uterine cancer	2.43e-05	5.45e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EP300—uterine cancer	2.43e-05	5.45e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMAD3—uterine cancer	2.4e-05	5.4e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—uterine cancer	2.4e-05	5.39e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HRAS—uterine cancer	2.37e-05	5.33e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—HRAS—uterine cancer	2.37e-05	5.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—HRAS—uterine cancer	2.36e-05	5.31e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—uterine cancer	2.35e-05	5.29e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTEN—uterine cancer	2.34e-05	5.25e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—AKT1—uterine cancer	2.33e-05	5.24e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—uterine cancer	2.32e-05	5.22e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—uterine cancer	2.31e-05	5.2e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—uterine cancer	2.3e-05	5.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGFR2—uterine cancer	2.29e-05	5.15e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NRAS—uterine cancer	2.27e-05	5.1e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—uterine cancer	2.24e-05	5.03e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—uterine cancer	2.23e-05	5.02e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EP300—uterine cancer	2.23e-05	5.01e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HRAS—uterine cancer	2.18e-05	4.89e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—uterine cancer	2.17e-05	4.89e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—uterine cancer	2.15e-05	4.82e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HRAS—uterine cancer	2.14e-05	4.81e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—uterine cancer	2.14e-05	4.8e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CXCL8—uterine cancer	2.12e-05	4.76e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—uterine cancer	2.11e-05	4.74e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—AKT1—uterine cancer	2.09e-05	4.7e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—AKT1—uterine cancer	2.09e-05	4.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—uterine cancer	2.09e-05	4.69e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—AKT1—uterine cancer	2.09e-05	4.69e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NRAS—uterine cancer	2.09e-05	4.69e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—AKT1—uterine cancer	2.07e-05	4.65e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1B—uterine cancer	2.07e-05	4.65e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—uterine cancer	2.07e-05	4.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—uterine cancer	2.06e-05	4.62e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—uterine cancer	2e-05	4.49e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HRAS—uterine cancer	1.98e-05	4.44e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—uterine cancer	1.97e-05	4.43e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ESR1—uterine cancer	1.96e-05	4.41e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—uterine cancer	1.96e-05	4.39e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—uterine cancer	1.95e-05	4.39e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—uterine cancer	1.93e-05	4.34e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—AKT1—uterine cancer	1.92e-05	4.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—uterine cancer	1.92e-05	4.31e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTEN—uterine cancer	1.91e-05	4.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1B—uterine cancer	1.9e-05	4.28e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—AKT1—uterine cancer	1.89e-05	4.25e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HRAS—uterine cancer	1.85e-05	4.15e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EP300—uterine cancer	1.82e-05	4.08e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—uterine cancer	1.8e-05	4.04e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—uterine cancer	1.79e-05	4.03e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—uterine cancer	1.79e-05	4.03e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HRAS—uterine cancer	1.78e-05	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTEN—uterine cancer	1.75e-05	3.94e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—AKT1—uterine cancer	1.75e-05	3.94e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—AKT1—uterine cancer	1.74e-05	3.92e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—uterine cancer	1.74e-05	3.9e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCL2—uterine cancer	1.73e-05	3.88e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—uterine cancer	1.72e-05	3.87e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NRAS—uterine cancer	1.7e-05	3.82e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—AKT1—uterine cancer	1.69e-05	3.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EP300—uterine cancer	1.67e-05	3.76e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HRAS—uterine cancer	1.66e-05	3.73e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—uterine cancer	1.65e-05	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—AKT1—uterine cancer	1.63e-05	3.67e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—AKT1—uterine cancer	1.61e-05	3.62e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—uterine cancer	1.6e-05	3.58e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—AKT1—uterine cancer	1.57e-05	3.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NRAS—uterine cancer	1.56e-05	3.51e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HRAS—uterine cancer	1.53e-05	3.43e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—AKT1—uterine cancer	1.47e-05	3.29e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—uterine cancer	1.46e-05	3.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—uterine cancer	1.44e-05	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL8—uterine cancer	1.37e-05	3.07e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—AKT1—uterine cancer	1.35e-05	3.03e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—uterine cancer	1.35e-05	3.02e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—uterine cancer	1.34e-05	3.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1B—uterine cancer	1.33e-05	3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—uterine cancer	1.3e-05	2.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—uterine cancer	1.26e-05	2.83e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HRAS—uterine cancer	1.24e-05	2.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—uterine cancer	1.24e-05	2.78e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTEN—uterine cancer	1.23e-05	2.76e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EP300—uterine cancer	1.17e-05	2.63e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HRAS—uterine cancer	1.14e-05	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—uterine cancer	1.11e-05	2.49e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AKT1—uterine cancer	1.1e-05	2.47e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NRAS—uterine cancer	1.1e-05	2.46e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—AKT1—uterine cancer	1.09e-05	2.45e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—AKT1—uterine cancer	1.01e-05	2.27e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—uterine cancer	9.43e-06	2.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—uterine cancer	8.66e-06	1.95e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—uterine cancer	8.38e-06	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HRAS—uterine cancer	8.01e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKT1—uterine cancer	7.08e-06	1.59e-05	CbGpPWpGaD
